INVA
Innoviva Inc
NASDAQ: INVA · HEALTHCARE · BIOTECHNOLOGY
$21.12
+0.86% today
Updated 2026-10-28
Market cap
$1.50B
P/E ratio
4.86
P/S ratio
3.41x
EPS (TTM)
$4.28
Dividend yield
—
52W range
$17 – $25
Volume
0.8M
Innoviva Inc (INVA) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$21.12
12-Month target
$27.74
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.4B | $0.3B | $0.3B | $0.4B | $0.4B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 4.86x (capped 25x) · Margin: 81.20%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.